BCX 1470

BCX 1470 inhibits the esterolytic activity of factor D (IC50=96 nM) and C1s (IC50=1.6 nM), 3.4- and 200-fold better, respectively, than that of trypsin.

Product Specifications

CAS Number

[217099-43-9]

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Complement System

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/bcx-1470.html

Solubility

10 mM in DMSO

Smiles

N=C(C1=CC2=CC=C(OC(C3=CC=CS3)=O)C=C2S1)N

Molecular Formula

C14H10N2O2S2

Molecular Weight

302.37

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Szalai, Alexander J.; Digerness, Stanley B.; et al.; The Arthus Reaction in Rodents: Species-Specific Requirement of ComplementJournal of Immunology, 2000, 164, 463-468